Which Probiotics Have Been Studied For Their Effects On Anxiety And Depression Symptoms In Humans?

Probiotics, particularly certain strains of Lactobacillus and Bifidobacterium, have shown potential benefits in reducing symptoms of anxiety and depression. High-quality evidence supports strains such as Lactiplantibacillus plantarum, Lactobacillus rhamnosus HN001, Bifidobacterium longum NCC3001, and multispecies probiotic formulations in improving mood, anxiety, and depression symptoms in various populations. However, effects vary by strain, dose, population, and study design, and more research is needed to optimize treatment.

Very low
Low
Moderate
High
Certainty not assessed
This analysis does not carry a graded certainty rating. Read the limitations section before drawing conclusions.

What the research shows

Multiple high-quality randomized controlled trials and meta-analyses indicate that probiotics can reduce symptoms of depression and anxiety. Meta-analyses (PMID: 39731509, 34620373, 41310510, 40440772) show significant reductions in depression and anxiety scores with probiotic supplementation, though heterogeneity exists. Specific strains with evidence include Lactiplantibacillus plantarum (PMID: 40312029, 40008414), Lactobacillus rhamnosus HN001 (PMID: 28943228), Bifidobacterium longum NCC3001 (PMID: 28483500), and multispecies probiotics (PMID: 30991255, 40222448). Some studies report improvements in mood and anxiety in healthy adults, postpartum women, patients with irritable bowel syndrome, and cancer patients undergoing chemotherapy. Mechanisms involve modulation of neurotransmitters (GABA, serotonin), immune regulation, and gut-brain axis signaling. Evidence for prebiotics is less consistent. Safety profiles are generally favorable with no serious adverse events reported. Limitations include variability in strains, doses, populations, and study durations, as well as some inconsistent findings and need for long-term data.

Best studied probiotic strains

Lactiplantibacillus plantarum

High-quality RCTs demonstrated significant anxiety reduction in adults with mild to moderate anxiety (PMID: 40312029) and improved mood and immunity in healthy women (PMID: 40008414).

Studied for: Anxiety, depression, general mental wellbeing

Effects observed with doses around 9 log CFU/day over 6-12 weeks; mechanisms include neurotransmitter modulation and immune gene expression.

Lactobacillus rhamnosus HN001

RCT showed reduced postpartum depression and anxiety symptoms in women receiving HN001 during pregnancy and postpartum (PMID: 28943228).

Studied for: Postpartum depression and anxiety

May be particularly useful in perinatal mental health; administered from mid-pregnancy to 6 months postpartum.

Bifidobacterium longum NCC3001

RCT in IBS patients showed significant reduction in depression scores and altered brain activity related to emotional processing (PMID: 28483500).

Studied for: Depression in irritable bowel syndrome

Effects on depression but not anxiety; associated with changes in limbic brain regions.

Multispecies probiotic formulations

RCTs and meta-analyses indicate multispecies probiotics reduce anxiety and depression symptoms in healthy and clinical populations (PMID: 30991255, 40222448, 40077722).

Studied for: Anxiety, depression

Formulations vary; longer duration (≥8 weeks) and higher doses may improve efficacy.

Lacticaseibacillus paracasei and Lactobacillus acidophilus (in cultured milk drink)

RCT showed reduction in depression scores and increased serotonin levels in IBS patients with subthreshold depression (PMID: 38658619).

Studied for: Depression in IBS

Potential as adjunctive treatment in IBS-related mood disturbances.

View products containing microorganisms linked to this analysis

Who may benefit

Adults with mild to moderate anxiety or depression symptoms Postpartum women experiencing depression and anxiety Patients with irritable bowel syndrome and comorbid depression Cancer patients undergoing gastrointestinal surgery and chemotherapy at risk of depression and anxiety Generally healthy adults seeking mood and mental wellbeing support Women with polycystic ovary syndrome experiencing depression and anxiety (limited evidence)

Safety

Probiotic supplementation is generally safe with no serious adverse events reported in the reviewed studies. Some studies specifically noted no adverse effects over intervention periods ranging from weeks to months. However, long-term safety data are limited and should be further investigated.

Limitations

There is considerable heterogeneity in probiotic strains, doses, treatment durations, and populations studied, which limits direct comparisons and generalizability. Some studies show inconsistent or modest effects, and the mechanisms of action are not fully elucidated. Evidence for prebiotics and synbiotics is less robust. Many studies have small sample sizes or short follow-up periods. More large-scale, well-designed RCTs with standardized protocols and long-term follow-up are needed to confirm efficacy and safety and to identify optimal strains and treatment regimens.

PubMed sources

Study Type Year PMID
The psychobiotic revolution: comprehending the optimistic role of gut microbiota on gut-brain axis during neurological and Gastrointestinal (GI) disorders.
World journal of microbiology & biotechnology
Research Study 2025 41129047
Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders.
Journal of food and drug analysis
Research Study 2019 31324280
The Role of Gut Microbiota in Anxiety, Depression, and Other Mental Disorders as Well as the Protective Effects of Dietary Components.
Nutrients
Research Study 2023 37513676
Psychobiotics Ameliorate Depression and Anxiety Status in Surgical Oncology Patients: Results from the Study.
Nutrients
Randomized Controlled Trial 2025 40077722
Maternal mood, anxiety and mental health functioning after combined myo-inositol, probiotics, micronutrient supplementation from preconception: Findings from the NiPPeR RCT.
Psychiatry research
Randomized Controlled Trial 2024 38402742
Fermented Vegetables as a Source of Psychobiotics: A Review of the Evidence for Mental Health Benefits.
Probiotics and antimicrobial proteins
Research Study 2026 40402417
From isoniazid to psychobiotics: the gut microbiome as a new antidepressant target.
British journal of hospital medicine (London, England : 2005)
Research Study 2019 30860919
Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Nutrition reviews
Meta-analysis 2025 39731509
Probiotics for the treatment of depression and anxiety: A systematic review and meta-analysis of randomized controlled trials.
Clinical nutrition ESPEN
Meta-analysis 2021 34620373
Heat-killed improves mood states: a randomised, double-blind, placebo-controlled study.
Beneficial microbes
Randomized Controlled Trial 2023 37026368
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics".
International journal of molecular sciences
Systematic Review 2025 40076598
The efficacy of probiotics, prebiotics, and synbiotics on anxiety, depression, and sleep: a systematic review and meta-analysis of randomized controlled trials.
BMC psychiatry
Meta-analysis 2025 41310510
Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders.
CNS & neurological disorders drug targets
Systematic Review 2014 25470391
Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Gastroenterology
Randomized Controlled Trial 2017 28483500
Psychobiotics Regulate the Anxiety Symptoms in Carriers of Allele A of IL-1 Gene: A Randomized, Placebo-Controlled Clinical Trial.
Mediators of inflammation
Randomized Controlled Trial 2020 32377159
Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial.
EBioMedicine
Randomized Controlled Trial 2017 28943228
Can psychobiotics "mood" ify gut? An update systematic review of randomized controlled trials in healthy and clinical subjects, on anti-depressant effects of probiotics, prebiotics, and synbiotics.
Clinical nutrition (Edinburgh, Scotland)
Systematic Review 2020 31307840
Efficacy of spp. Interventions to Modulate Mood Symptoms: A Scoping Review of Clinical Trials.
International journal of molecular sciences
Research Study 2025 40869419
Lactiplantibacillus plantarum Lp815 decreases anxiety in people with mild to moderate anxiety: a direct-to-consumer, randomised, double-blind, placebo-controlled study.
Beneficial microbes
Randomized Controlled Trial 2025 40312029
Effectiveness of Psychobiotics in the Treatment of Psychiatric and Cognitive Disorders: A Systematic Review of Randomized Clinical Trials.
Nutrients
Systematic Review 2024 38732599
Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review.
Nutritional neuroscience
Systematic Review 2021 31858898
The gut-brain relationship: Investigating the effect of multispecies probiotics on anxiety in a randomized placebo-controlled trial of healthy young adults.
Journal of affective disorders
Randomized Controlled Trial 2019 30991255
Exploring the acute and chronic effects of a multistrain probiotic supplement on cognitive function and mood in healthy older adults: a randomized controlled trial.
The American journal of clinical nutrition
Randomized Controlled Trial 2025 40222448
Psychobiotics in Depression: Sources, Metabolites, and Treatment-A Systematic Review.
Nutrients
Systematic Review 2025 40647242
Probiotic enhanced immunity and mental wellbeing of generally healthy women: a randomised, placebo-controlled and double-blind study.
Beneficial microbes
Randomized Controlled Trial 2025 40008414
Brain-Gut-Microbiota Axis and Mental Health.
Psychosomatic medicine
Research Study 2017 28806201
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics.
Critical reviews in food science and nutrition
Research Study 2022 33955288
Microbiome modulation as a novel therapeutic modality for anxiety disorders: A review of clinical trials.
Behavioural brain research
Systematic Review 2025 40246176
The impact of ingestion of Bifidobacterium longum NCC3001 on perinatal anxiety and depressive symptoms: a randomized controlled trial.
Scientific reports
Randomized Controlled Trial 2025 40175540
Probiotic intake and mental health in healthy working adults: a systematic review and meta-analysis of randomized controlled trials.
BMC psychology
Meta-analysis 2026 41501907
The Immune Mind: Linking Dietary Patterns, Microbiota, and Psychological Health.
Nutrients
Meta-analysis 2025 41515213
The Impact of BC99 on Anxiety and Depression: An 8-Week Clinical Pilot Study Through the Gut Microbiota-Brain Axis.
Nutrients
Randomized Controlled Trial 2025 41097163
Protective Effects of Probiotics on Runners' Mood: Immunometabolic Mechanisms Post-Exercise.
Nutrients
Randomized Controlled Trial 2024 39519594
Impact of consuming a milk drink containing a probiotic on mood and cognition.
European journal of clinical nutrition
Randomized Controlled Trial 2007 17151594
Estrogenic Effect of Probiotics on Anxiety and Depression: A Narrative Review.
International journal of molecular sciences
Research Study 2025 41155243
Psychobiotics and the microbiota-gut-brain axis: Emerging paradigms in mental health modulation.
Experimental physiology
Research Study 2026 41762172
Effects of Probiotic Supplementation on Mental Health and the Risk of Depression in Women with Polycystic Ovary Syndrome: A Systematic Review of Randomized Controlled Trials.
Nutrients
Systematic Review 2026 41599922
The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System-A Systematic Review.
International journal of molecular sciences
Systematic Review 2022 35887166
Probiotics and Maternal Mental Health: A Randomised Controlled Trial among Pregnant Women with Obesity.
Scientific reports
Randomized Controlled Trial 2020 31992802
Probiotics for the treatment of depression and its comorbidities: A systemic review.
Frontiers in cellular and infection microbiology
Systematic Review 2023 37139495
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
Scientific reports
Randomized Controlled Trial 2024 38658619
Effectiveness of probiotic/prebiotic/synbiotic treatments on anxiety: A systematic review and meta-analysis of randomized controlled trials.
Journal of affective disorders
Meta-analysis 2023 37734624

Products containing microorganisms linked to this analysis

These products contain microorganisms identified in the research analysis above.